Welcome, Ramesh Raskar

This profile has not been claimed and data may not be accurate.

Founder55

37th percentile

Investor81

90th percentile

Combined136
Serial FounderAcquiredAngel InvestorOn Wikipedia

Investor Matrix

Credibility

Portfolio 63Exits 95Firm 93Experience 96Capital 49
this founder typical investor (50th pct)

Experience · 96th percentile

  • Has approximately 14 years of investing experience, with his investor/advisor role listed from January 2009 to present.

Founder score

  • 95%Probability of being accurate (95%)Wikidata and Wikipedia entity exists for Ramesh Raskar, confirming public notability.
  • 88%Probability of being accurate (88%)Current co-founder of C10 Labs, a venture studio fund, and founder of Project NANDA and PathCheck Foundation.
  • 82%Probability of being accurate (82%)Exit: Akasha.im was acquired by Intrinsic, an Alphabet spin-off.
  • 80%Probability of being accurate (80%)Past founder of multiple companies including PathCheck Foundation and spin-offs from his MIT Camera Culture group.
  • 80%Probability of being accurate (80%)Companies he founded had co-founders, including C10 Labs where he is listed as co-founder.
  • 70%Probability of being accurate (70%)Majestic Million bonus: LinkedIn (lnkd.in) is ranked #454 in the Majestic Million, a domain associated with his professional presence.

Investor score

  • 85%Probability of being accurate (85%)Active GP and co-founder of C10 Labs, a venture studio fund dedicated to AI-first startups.
  • 82%Probability of being accurate (82%)Publicly identified as an angel investor and advisor to numerous startups including Vayu Robotics, Photoneo, Glass Imaging, Algoface, and others.
  • 78%Probability of being accurate (78%)Portfolio company LendBuzz reached unicorn status (valuation over $1B).
  • 75%Probability of being accurate (75%)Has approximately 14 years of investing experience, with his investor/advisor role listed from January 2009 to present.
  • 72%Probability of being accurate (72%)Has made investments in at least 7 distinct companies including Vayu Robotics, Photoneo, Ubicept, Glass Imaging, Algoface, Aikriti.ai, and S10.ai.

What you likely need

Ramesh Raskar is a prolific MIT professor-entrepreneur with a strong track record of spinning out companies and investing in deep-tech startups. His current focus on Project NANDA and C10 Labs positions him at the frontier of AI agent infrastructure, where his academic credibility and inventor reputation are powerful differentiators. To maximize impact, he should leverage his network and IP portfolio to accelerate commercialization of his most promising ventures.

Are these your current priorities?

We will tune and customize your Founder Festival experience to make sure you get invited to the events that would be most valuable to you.

  • fundraisingFormalize and publicize C10 Labs' fund size and thesis to attract LP capital from institutional investors who back deep-tech venture studios.
  • positioningPosition Project NANDA's Internet of AI Agents framework as the open standard for agentic interoperability, publishing a technical whitepaper to drive adoption and inbound partnership interest.
  • tacticalExplore licensing or spin-out opportunities for the 132 patents in computer vision and computational health to generate non-dilutive revenue for portfolio companies.
  • hiringEstablish a formal MIT Camera Culture spin-out pipeline with C10 Labs as the first institutional home, giving student founders a clear path from lab to funded company.
  • fundraisingLaunch a named angel syndicate on AngelList or a similar platform to pool co-investment from your network into Camera Culture spin-offs, increasing deal flow and follow-on capacity.
  • positioningTranslate your Lemelson Prize and SIGGRAPH Award recognition into a consistent thought-leadership presence (podcast appearances, op-eds) specifically around AI agent infrastructure to attract enterprise partners for NANDA.
  • fundraisingPursue NIH, Wellcome Trust, or Gates Foundation grants for your low-cost eye care and health-tech devices (Netra, EyeSelfie) to fund commercialization in emerging markets without diluting equity.